Follow
Fabien Boulle
Fabien Boulle
Neuropharmacologist / Entrepreneur
Verified email at np.unimaas.nl - Homepage
Title
Cited by
Cited by
Year
Epigenetic regulation of the BDNF gene: implications for psychiatric disorders
F Boulle, DLA Van Den Hove, SB Jakob, BP Rutten, M Hamon, J Van Os, ...
Molecular psychiatry 17 (6), 584-596, 2012
3212012
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
MJF Levy, F Boulle, HW Steinbusch, DLA van den Hove, G Kenis, ...
Psychopharmacology 235, 2195-2220, 2018
1962018
Hippocampal and behavioral dysfunctions in a mouse model of environmental stress: normalization by agomelatine
F Boulle, R Massart, E Stragier, E Paļzanis, L Zaidan, S Marday, C Gabriel, ...
Translational psychiatry 4 (11), e485-e485, 2014
872014
Developmental fluoxetine exposure increases behavioral despair and alters epigenetic regulation of the hippocampal BDNF gene in adult female offspring
F Boulle, JL Pawluski, JR Homberg, B Machiels, Y Kroeze, N Kumar, ...
Hormones and behavior 80, 47-57, 2016
832016
Prenatal stress and early‐life exposure to fluoxetine have enduring effects on anxiety and hippocampal BDNF gene expression in adult male offspring
F Boulle, JL Pawluski, JR Homberg, B Machiels, Y Kroeze, N Kumar, ...
Developmental psychobiology 58 (4), 427-438, 2016
792016
TrkB inhibition as a therapeutic target for CNS-related disorders
F Boulle, G Kenis, M Cazorla, M Hamon, HWM Steinbusch, L Lanfumey, ...
Progress in neurobiology 98 (2), 197-206, 2012
792012
Ethanol-induced epigenetic regulations at the Bdnf gene in C57BL/6J mice
E Stragier, R Massart, M Salery, M Hamon, D Geny, V Martin, F Boulle, ...
Molecular psychiatry 20 (3), 405-412, 2015
592015
5-HTT independent effects of fluoxetine on neuroplasticity
MJF Levy, F Boulle, MB Emerit, C Poilbout, HWM Steinbusch, ...
Scientific Reports 9 (1), 6311, 2019
312019
Long-term consequences of chronic fluoxetine exposure on the expression of myelination-related genes in the rat hippocampus
Y Kroeze, D Peeters, F Boulle, DLA Van Den Hove, H Van Bokhoven, ...
Translational psychiatry 5 (9), e642-e642, 2015
312015
Behavioral and neurochemical characterization of TrkB-dependent mechanisms of agomelatine in glucocorticoid receptor-impaired mice
F Boulle, H Velthuis, K Koedam, HW Steinbusch, DLA van den Hove, ...
European Neuropsychopharmacology 26 (1), 65-77, 2016
192016
Epigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders
F Boulle
22013
Is the effect of fluoxetine on plasticity related to serotonin transporter or tropomyosin-related receptor kinase B?
MJF Levy, F Boulle, MB Emerit, HW Steinbusch, D Van den Hove, G Kenis, ...
European Neuropsychopharmacology 29, S348, 2019
2019
Effect of fluoxetine and MIML4–11, a novel tropomyosin-related kinase receptor agonist, in a lipopolysaccharide-induced model of depression
MJF Levy, F Boulle, VS Martin, C Poilbout, D Rognan, L Lanfumey
European Neuropsychopharmacology 25, S292-S293, 2015
2015
Effect of fluoxetine on brain-derived neurotrophic factor-mediated signalling in primary cortical neurons
M Levy, E Stragier, MB Emerit, F Boulle, L Lanfumey
European Neuropsychopharmacology 25, S15-S15, 2015
2015
The Impact of Fluoxetine Treatment on BDNF Signaling and Cellular Plasticity in the Brain
J De Vry, F Boulle, BPF Rutten, DLA van den Hove, J Prickaerts
PHARMACOLOGY, MECHANISMS OF ACTION AND POTENTIAL SIDE EFFECTS, 71, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–15